
CapVest acquires majority stake in €10bn German drugmaker Stada from Bain and Cinven
CapVest Partners has agreed to acquire a majority stake in Stada Arzneimittel AG, buying control of the German pharmaceuticals group from existing private equity owners Bain Capital and Cinven, who will retain a minority interest, according to a report by Bloomberg.
